{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:03:58Z","timestamp":1720109038363},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.amjcard.2016.05.025","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T20:14:33Z","timestamp":1473452073000},"page":"1A-3A","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Introduction: What Have We Learned Since the 2013 ACC\/AHA Guidelines?"],"prefix":"10.1016","volume":"118","author":[{"given":"Roger S.","family":"Blumenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurram","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25 suppl 2","key":"10.1016\/j.amjcard.2016.05.025_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.05.025_bib2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (adult treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.05.025_bib3","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"370","author":"Pencina","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.05.025_bib4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.05.025_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11883-014-0438-9","article-title":"A\u00a0look at statin cost-effectiveness in view of the 2013 ACC\/AHA cholesterol management guidelines","volume":"16","author":"Dea\u00f1o","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.amjcard.2016.05.025_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.6822","article-title":"Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease","volume":"314","author":"Pandya","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.05.025_bib7","doi-asserted-by":"crossref","first-page":"h3902","DOI":"10.1136\/bmj.h3902","article-title":"Use of controversial ACC\/AHA guidelines for statin therapy is supported by US studies","volume":"351","author":"McCarthy","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2016.05.025_bib8","first-page":"1141022","article-title":"PCSK9: a key modulator of cardiovascular health","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2016.05.025_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jacl.2011.08.007","article-title":"Antisense therapy and emerging applications for the management of dyslipidemia","volume":"5","author":"Toth","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2016.05.025_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3909\/ricm0702","article-title":"Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice","volume":"15","author":"Toth","year":"2014","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2016.05.025_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcna.2012.01.009","article-title":"LDL cholesterol: the lower the better","volume":"96","author":"Martin","year":"2012","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.amjcard.2016.05.025_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCOUTCOMES.115.002207","article-title":"Overhauling cardiovascular risk prediction in primary prevention: difficult journey worth the destination","volume":"8","author":"Nasir","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916308797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916308797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:06:28Z","timestamp":1657245988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916308797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002914916308797"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.05.025","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction: What Have We Learned Since the 2013 ACC\/AHA Guidelines?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}